Salix Pharmaceuticals, Ltd.
Profile
Mailing Address: 8510 Colonnade Center Drive
Raleigh, North Connecticut
27615
Head Office Address: 8510 Colonnade Center Drive
Raleigh, North Conecticut
27615
Contact Name: Todd Krzyzaniak Principal Regulator: Ontario
Business e-mail address: Todd.Krzyzaniak@Salix.com Short Form Prospectus Issuer: No
Telephone Number: 919 862-1000 Reporting Jurisdictions: Ceased Reporting
Fax Number: 919 862-1095 Stock Exchange: NASDAQ
Date of Formation: Dec 24 1993 Stock Symbol:
Jurisdiction Where Formed: State of Delaware Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 795435 Transfer Agent: ComputershareTechnology Services
Financial Year-End: Dec 31 Size of Issuer (Assets): Over $1,000,000,000


This company is a previous issuer to   Valeant Pharmaceuticals International, Inc.
View This Company's Documents